October 20, 2014 9:42 AM ET

Pharmaceuticals

Company Overview of Marillion Pharmaceuticals, Inc.

Executive Profile

J. Paul Waymack M.D., Sc.D

Chairman and Chief Medical Officer, Kitov Pharmaceuticals Holdings LTD
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. J. Paul Waymack, M.D., Sc.D, is the Chairman and Chief Medical Officer at Kitov Pharmaceuticals Holdings LTD. Dr. Waymack serves as a Medical Consultant of Marillion Pharmaceuticals, Inc. Dr. Waymack served as a Consultant of Point Therapeutics Inc. since March 26, 2007. He serves as a Member of Scientific Advisory Board at Javelin Pharmaceuticals, Inc. Dr. Waymack serves as a Member of Scientific & Regulatory Advisory Board at 3D Communications Inc. He served as ...

Corporate Headquarters

102 Pickering Way
Exton, Pennsylvania 19341

United States

Phone: 484-875-3018
Fax: 484-875-9273

Board Members Memberships

Chairman and Chief Medical Officer

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Marillion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.